Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect TGex
News and Views Disease Lists/Categories
About
About MalaCards Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
THCYT1
MCID: THR090
MIFTS: 38

Thrombocythemia 1 (THCYT1)

Categories: Blood diseases, Bone diseases, Cancer diseases, Genetic diseases, Immune diseases, Rare diseases
Genes Variations Tissues Related diseases Publications Pathways Symptoms & Phenotypes Drugs
Sources

Aliases & Classifications for Thrombocythemia 1

About this section

MalaCards integrated aliases for Thrombocythemia 1:

Name: Thrombocythemia 1 58 76 13 74
Thrombocytosis 1 58 76
Thcyt1 58 76
Thrombocythemia, Essential 74
Essential Thrombocythemia 76
Thrombocythemia, Somatic 58
Thrombocythemia, Type 1 41

Characteristics:

OMIM:

58
Inheritance:
autosomal dominant


HPO:

33
thrombocythemia 1:
Inheritance somatic mutation autosomal dominant inheritance


Classifications:

MalaCards categories:
Global: Genetic diseases Cancer diseases Rare diseases
Anatomical: Blood diseases Bone diseases Immune diseases
See all MalaCards categories (disease lists)


Sources

Summaries for Thrombocythemia 1

About this section
OMIM : 58 Thrombocythemia, or thrombocytosis, is a myeloproliferative disorder characterized by excessive platelet production resulting in increased numbers of circulating platelets. Thrombocythemia can be associated with thrombotic or hemorrhagic episodes and occasional leukemic transformation (summary by Wiestner et al., 1998). (187950)

MalaCards based summary : Thrombocythemia 1, also known as thrombocytosis 1, is related to thrombocytosis and myeloproliferative neoplasm. An important gene associated with Thrombocythemia 1 is THPO (Thrombopoietin), and among its related pathways/superpathways are Response to elevated platelet cytosolic Ca2+ and Visual Cycle in Retinal Rods. The drugs Hydroxyurea and Aspirin have been mentioned in the context of this disorder. Affiliated tissues include bone marrow, myeloid and skin, and related phenotypes are hypertension and splenomegaly

UniProtKB/Swiss-Prot : 76 Thrombocythemia 1: A myeloproliferative disorder characterized by excessive platelet production, resulting in increased numbers of circulating platelets. It can be associated with spontaneous hemorrhages and thrombotic episodes.

Sources

Related Diseases for Thrombocythemia 1

About this section

Diseases in the Essential Thrombocythemia family:

Thrombocythemia 1 Thrombocythemia 2
Thrombocythemia 3

Diseases related to Thrombocythemia 1 via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 159)
# Related Disease Score Top Affiliating Genes
1 thrombocytosis 32.4 MPL THPO
2 myeloproliferative neoplasm 31.6 CALR MPL SH2B3
3 polycythemia 31.2 CALR MPL THPO
4 polycythemia vera 31.2 CALR MPL THPO
5 thrombocytopenia 30.6 MPL THPO
6 leukemia, chronic myeloid 30.3 MPL THPO
7 myelofibrosis 30.3 CALR MPL SH2B3 THPO
8 thrombocytopenic purpura, autoimmune 30.0 MPL THPO
9 purpura 30.0 MPL THPO
10 thrombocytopenia due to platelet alloimmunization 29.8 MPL THPO
11 aplastic anemia 29.3 MPL THPO
12 essential thrombocythemia 28.8 CALR MPL SH2B3 THPO
13 acquired von willebrand syndrome 11.6
14 thrombocythemia 3 11.2
15 thrombosis 10.8
16 leukemia 10.8
17 myocardial infarction 10.6
18 myeloid leukemia 10.6
19 leukemia, acute myeloid 10.5
20 lymphocytic leukemia 10.4
21 acute myocardial infarction 10.4
22 myeloma, multiple 10.4
23 leukemia, chronic lymphocytic 2 10.3
24 leukemia, chronic lymphocytic 10.3
25 ischemia 10.3
26 leukemia, b-cell, chronic 10.3
27 myelodysplastic syndrome 10.3
28 acute leukemia 10.3
29 lymphoma 10.3
30 budd-chiari syndrome 10.3
31 erythromelalgia 10.3
32 heparin-induced thrombocytopenia 10.3
33 sarcoma 10.2
34 myeloid sarcoma 10.2
35 platelet membrane fluidity 10.2
36 thrombophilia due to thrombin defect 10.2
37 stroke, ischemic 10.2
38 leukemia, acute lymphoblastic 10.2
39 von willebrand's disease 10.2
40 acute biphenotypic leukemia 10.1
41 thrombophilia 10.1
42 splenomegaly 10.1
43 refractory anemia 10.1
44 thrombocytopenia 3 10.0 MPL THPO
45 dyskeratosis congenita, autosomal dominant 6 10.0 MPL THPO
46 amegakaryocytic thrombocytopenia, congenital 10.0 MPL THPO
47 primary thrombocytopenia 10.0 MPL THPO
48 thrombophilia due to activated protein c resistance 10.0
49 thrombocythemia 2 10.0
50 coronary heart disease 1 10.0

Graphical network of the top 20 diseases related to Thrombocythemia 1:



Diseases related to Thrombocythemia 1
Sources

Symptoms & Phenotypes for Thrombocythemia 1

About this section

Human phenotypes related to Thrombocythemia 1:

33 (show all 7)
# Description HPO Frequency HPO Source Accession
1 hypertension 33 HP:0000822
2 splenomegaly 33 HP:0001744
3 acrocyanosis 33 HP:0001063
4 abnormality of the skeletal system 33 HP:0000924
5 thrombocytosis 33 HP:0001894
6 myeloproliferative disorder 33 HP:0005547
7 impaired platelet aggregation 33 HP:0003540

Symptoms via clinical synopsis from OMIM:

58
Cardiovascular Vascular:
thrombotic episodes
hemorrhagic episodes

Laboratory Abnormalities:
increased serum thrombopoietin may occur

Hematology:
thrombocythemia
increased bone marrow megakaryocytes

Clinical features from OMIM:

187950
Sources

Drugs & Therapeutics for Thrombocythemia 1

About this section

Drugs for Thrombocythemia 1 (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 13)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Hydroxyurea Approved Not Applicable 127-07-1 3657
2
Aspirin Approved, Vet_approved Not Applicable 50-78-2 2244
3 Antipyretics Not Applicable
4 Fibrinolytic Agents Not Applicable
5 Analgesics Not Applicable
6 Antirheumatic Agents Not Applicable
7 Cyclooxygenase Inhibitors Not Applicable
8 Anti-Inflammatory Agents Not Applicable
9 Peripheral Nervous System Agents Not Applicable
10 Analgesics, Non-Narcotic Not Applicable
11 Platelet Aggregation Inhibitors Not Applicable
12 Anti-Inflammatory Agents, Non-Steroidal Not Applicable
13 Nucleic Acid Synthesis Inhibitors Not Applicable

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Primary Thrombocythaemia 1 Trial Completed NCT00175838 Not Applicable Hydroxyurea;Aspirin

Search NIH Clinical Center for Thrombocythemia 1

Inferred drug relations via UMLS 74 / NDF-RT 52 :
Sources

Genetic Tests for Thrombocythemia 1

About this section
Sources

Anatomical Context for Thrombocythemia 1

About this section

MalaCards organs/tissues related to Thrombocythemia 1:

42
Bone Marrow, Myeloid, Skin, B Cells, Placenta
Sources

Publications for Thrombocythemia 1

About this section

Articles related to Thrombocythemia 1:

# Title Authors Year
1
Management of essential thrombocythemia: implications of the medical research council primary thrombocythemia 1 trial. ( 16673283 )
2006
Sources

Variations for Thrombocythemia 1

About this section

ClinVar genetic disease variations for Thrombocythemia 1:

6 (show top 50) (show all 179)
# Gene Variation Type Significance SNP ID Assembly Location
1 THPO THPO, IVS3, G-C, +1 single nucleotide variant Pathogenic
2 THPO THPO, 1-BP DEL, 3252G deletion Pathogenic
3 THPO THPO, 516G-T single nucleotide variant Pathogenic
4 MPL NM_005373.2(MPL): c.117G> T (p.Lys39Asn) single nucleotide variant risk factor rs17292650 GRCh37 Chromosome 1, 43803807: 43803807
5 MPL NM_005373.2(MPL): c.117G> T (p.Lys39Asn) single nucleotide variant risk factor rs17292650 GRCh38 Chromosome 1, 43338136: 43338136
6 MPL NM_005373.2(MPL): c.1514G> A (p.Ser505Asn) single nucleotide variant Pathogenic/Likely pathogenic rs121913614 GRCh37 Chromosome 1, 43814979: 43814979
7 MPL NM_005373.2(MPL): c.1514G> A (p.Ser505Asn) single nucleotide variant Pathogenic/Likely pathogenic rs121913614 GRCh38 Chromosome 1, 43349308: 43349308
8 SH2B3 NM_005475.2(SH2B3): c.622G> C (p.Glu208Gln) single nucleotide variant Pathogenic rs202080221 GRCh37 Chromosome 12, 111856571: 111856571
9 SH2B3 NM_005475.2(SH2B3): c.622G> C (p.Glu208Gln) single nucleotide variant Pathogenic rs202080221 GRCh38 Chromosome 12, 111418767: 111418767
10 CALR NM_004343.3(CALR): c.1092_1143del52 (p.Leu367Thrfs) deletion Pathogenic rs1555760738 GRCh37 Chromosome 19, 13054565: 13054616
11 CALR NM_004343.3(CALR): c.1092_1143del52 (p.Leu367Thrfs) deletion Pathogenic rs1555760738 GRCh38 Chromosome 19, 12943751: 12943802
12 MPL NM_005373.2(MPL): c.340G> A (p.Val114Met) single nucleotide variant Benign/Likely benign rs12731981 GRCh38 Chromosome 1, 43338669: 43338669
13 MPL NM_005373.2(MPL): c.340G> A (p.Val114Met) single nucleotide variant Benign/Likely benign rs12731981 GRCh37 Chromosome 1, 43804340: 43804340
14 MPL NM_005373.2(MPL): c.690A> G (p.Glu230=) single nucleotide variant Benign rs16830693 GRCh38 Chromosome 1, 43339569: 43339569
15 MPL NM_005373.2(MPL): c.690A> G (p.Glu230=) single nucleotide variant Benign rs16830693 GRCh37 Chromosome 1, 43805240: 43805240
16 MPL NM_005373.2(MPL): c.962G> A (p.Arg321Gln) single nucleotide variant Benign/Likely benign rs149265851 GRCh37 Chromosome 1, 43806166: 43806166
17 MPL NM_005373.2(MPL): c.962G> A (p.Arg321Gln) single nucleotide variant Benign/Likely benign rs149265851 GRCh38 Chromosome 1, 43340495: 43340495
18 MPL NM_005373.2(MPL): c.1120A> G (p.Thr374Ala) single nucleotide variant Benign/Likely benign rs190983971 GRCh37 Chromosome 1, 43812255: 43812255
19 MPL NM_005373.2(MPL): c.1120A> G (p.Thr374Ala) single nucleotide variant Benign/Likely benign rs190983971 GRCh38 Chromosome 1, 43346584: 43346584
20 MPL NM_005373.2(MPL): c.1102G> T (p.Val368Leu) single nucleotide variant Conflicting interpretations of pathogenicity rs149810307 GRCh37 Chromosome 1, 43812237: 43812237
21 MPL NM_005373.2(MPL): c.1102G> T (p.Val368Leu) single nucleotide variant Conflicting interpretations of pathogenicity rs149810307 GRCh38 Chromosome 1, 43346566: 43346566
22 MPL NM_005373.2(MPL): c.1565+5C> T single nucleotide variant Conflicting interpretations of pathogenicity rs41269541 GRCh38 Chromosome 1, 43349364: 43349364
23 MPL NM_005373.2(MPL): c.1565+5C> T single nucleotide variant Conflicting interpretations of pathogenicity rs41269541 GRCh37 Chromosome 1, 43815035: 43815035
24 ATG2B; BDKRB1; BDKRB2; C14orf132; GSKIP; LOC107984703; TCL1A; TUNAR NC_000014.9: g.95696766_96390792dup duplication Likely pathogenic GRCh37 Chromosome 14, 96163103: 96857129
25 ATG2B; BDKRB1; BDKRB2; C14orf132; GSKIP; LOC107984703; TCL1A; TUNAR NC_000014.9: g.95696766_96390792dup duplication Likely pathogenic GRCh38 Chromosome 14, 95696766: 96390792
26 MPL NM_005373.2(MPL): c.210G> A (p.Pro70=) single nucleotide variant Likely benign rs6086 GRCh37 Chromosome 1, 43803900: 43803900
27 MPL NM_005373.2(MPL): c.210G> A (p.Pro70=) single nucleotide variant Likely benign rs6086 GRCh38 Chromosome 1, 43338229: 43338229
28 MPL NM_005373.2(MPL): c.92T> C (p.Leu31Pro) single nucleotide variant Uncertain significance rs878854771 GRCh38 Chromosome 1, 43338111: 43338111
29 MPL NM_005373.2(MPL): c.92T> C (p.Leu31Pro) single nucleotide variant Uncertain significance rs878854771 GRCh37 Chromosome 1, 43803782: 43803782
30 MPL NM_005373.2(MPL): c.844G> A (p.Gly282Arg) single nucleotide variant Uncertain significance rs878854770 GRCh37 Chromosome 1, 43805788: 43805788
31 MPL NM_005373.2(MPL): c.844G> A (p.Gly282Arg) single nucleotide variant Uncertain significance rs878854770 GRCh38 Chromosome 1, 43340117: 43340117
32 MPL NM_005373.2(MPL): c.1309-10C> T single nucleotide variant Benign/Likely benign rs139486615 GRCh37 Chromosome 1, 43814504: 43814504
33 MPL NM_005373.2(MPL): c.1309-10C> T single nucleotide variant Benign/Likely benign rs139486615 GRCh38 Chromosome 1, 43348833: 43348833
34 MPL NM_005373.2(MPL): c.1653+3G> A single nucleotide variant Benign/Likely benign rs149625825 GRCh37 Chromosome 1, 43817977: 43817977
35 MPL NM_005373.2(MPL): c.1653+3G> A single nucleotide variant Benign/Likely benign rs149625825 GRCh38 Chromosome 1, 43352306: 43352306
36 MPL NM_005373.2(MPL): c.1794C> T (p.Cys598=) single nucleotide variant Benign/Likely benign rs143457144 GRCh38 Chromosome 1, 43352658: 43352658
37 MPL NM_005373.2(MPL): c.1794C> T (p.Cys598=) single nucleotide variant Benign/Likely benign rs143457144 GRCh37 Chromosome 1, 43818329: 43818329
38 THPO NM_000460.4(THPO): c.1030A> G (p.Thr344Ala) single nucleotide variant Benign/Likely benign rs35794435 GRCh38 Chromosome 3, 184372545: 184372545
39 THPO NM_000460.4(THPO): c.1030A> G (p.Thr344Ala) single nucleotide variant Benign/Likely benign rs35794435 GRCh37 Chromosome 3, 184090333: 184090333
40 THPO NM_000460.4(THPO): c.229-17_229-14dup duplication Benign/Likely benign rs55827759 GRCh38 Chromosome 3, 184373596: 184373599
41 THPO NM_000460.4(THPO): c.229-17_229-14dup duplication Benign/Likely benign rs55827759 GRCh37 Chromosome 3, 184091384: 184091387
42 THPO NM_000460.4(THPO): c.*18G> A single nucleotide variant Uncertain significance rs180680111 GRCh37 Chromosome 3, 184090283: 184090283
43 THPO NM_000460.4(THPO): c.*18G> A single nucleotide variant Uncertain significance rs180680111 GRCh38 Chromosome 3, 184372495: 184372495
44 MPL NM_005373.2(MPL): c.196C> T (p.Leu66=) single nucleotide variant Uncertain significance rs886046349 GRCh38 Chromosome 1, 43338215: 43338215
45 MPL NM_005373.2(MPL): c.196C> T (p.Leu66=) single nucleotide variant Uncertain significance rs886046349 GRCh37 Chromosome 1, 43803886: 43803886
46 MPL NM_005373.2(MPL): c.543T> C (p.Gly181=) single nucleotide variant Benign/Likely benign rs17572791 GRCh38 Chromosome 1, 43339422: 43339422
47 MPL NM_005373.2(MPL): c.543T> C (p.Gly181=) single nucleotide variant Benign/Likely benign rs17572791 GRCh37 Chromosome 1, 43805093: 43805093
48 MPL NM_005373.2(MPL): c.1051C> T (p.Arg351Cys) single nucleotide variant Uncertain significance rs201998783 GRCh38 Chromosome 1, 43346515: 43346515
49 MPL NM_005373.2(MPL): c.1051C> T (p.Arg351Cys) single nucleotide variant Uncertain significance rs201998783 GRCh37 Chromosome 1, 43812186: 43812186
50 MPL NM_005373.2(MPL): c.1337G> A (p.Gly446Glu) single nucleotide variant Uncertain significance rs561724539 GRCh38 Chromosome 1, 43348871: 43348871
Sources

Expression for Thrombocythemia 1

About this section
Search GEO for disease gene expression data for Thrombocythemia 1.
Sources

Pathways for Thrombocythemia 1

About this section

Pathways related to Thrombocythemia 1 according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
Response to elevated platelet cytosolic Ca2+ 67
Show member pathways
 12.58 MPL SH2B3 THPO
2
Visual Cycle in Retinal Rods 65
11.13 MPL THPO
3
Integrin alphaIIb beta3 signaling 67
Show member pathways
 10.95 MPL THPO
4
Hematopoietic Stem Cell Differentiation Pathways and Lineage-specific Markers 66
10.86 MPL SH2B3 THPO
5
Development_Thrombopoetin signaling via JAK-STAT pathway 23
10.62 MPL THPO
Sources

GO Terms for Thrombocythemia 1

About this section

Biological processes related to Thrombocythemia 1 according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 thrombopoietin-mediated signaling pathway GO:0038163 8.62 MPL THPO
Sources

Sources for Thrombocythemia 1

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....